Transparent and dynamic network-based risk assessment for development of hepatic encephalopathy
Authors:
Open Access
- 10 December 2025
- journal article
- research article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Background Hepatic encephalopathy is a debilitating and resource-intensive complication of cirrhosis, with high prevalence, frequent hospitalizations, and poor prognosis. Precise and dynamic identification of at-risk individuals remains a major clinical challenge. Methods Combining expert knowledge with data-driven methodologies, we proposed a network-based risk assessment model by analyzing the inter-connections between cirrhotic complications and using routinely available blood test results. The model was developed (n = 2789) and validated (n = 698) in multi-etiology cirrhosis cohorts. Results Here we show hepatic encephalopathy as a pivotal nexus in the cirrhotic complication cascade. The presence of ascites (adjusted relative risk: 4.8), gastroesophageal varices (3.6), peritonitis (2.2), hepatorenal syndrome (2.1), gastroesophageal variceal hemorrhage (1.9) and hepatocellular carcinoma (1.5) is related with subsequent hepatic encephalopathy; all p < 0.05. Nine of 980 tests (ammonia, international normalized ratio, red cell distribution width standard deviation, fibrinogen, triglycerides, mean corpuscular hemoglobin, absolute neutrophil count, sodium, and total CO2) are selected through a stringent process encompassing clinical utility, expert agreement, risk direction clarity, and information non-redundancy. The network-based model accurately predicts hepatic encephalopathy risk in both cross-sectional and longitudinal settings, AUROC = 0.926 (95% confidence interval: 0.882-0.962) and 0.962 (0.933-0.984), respectively. It is compatible with missing data (i.e., using partially observed information) and offers flexible clinical implementation through a simple tool-free method and smart device integration. Clinical utility spans patient risk stratification, dynamic risk monitoring, optimized screening, and hepatic encephalopathy-related complication prevention. Conclusions This network-based approach provides transparent, precise and dynamic risk assessment in hepatic encephalopathy management, with potential to improve clinical outcomes in cirrhotic patients.Keywords
This publication has 40 references indexed in Scilit:
- Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop‐CN model (NCRCID‐CHESS 2106): a prospective multicenter studyMedcomm, 2024
- The assessment and management of cirrhotic patients with encephalopathyUnited European Gastroenterology Journal, 2024
- Identifying Minimal Hepatic Encephalopathy: A New Perspective from Magnetic Resonance ImagingJournal of Magnetic Resonance Imaging, 2023
- Diagnosis and Management of Cirrhosis and Its ComplicationsJAMA, 2023
- Predicting which patients with cirrhosis will develop overt hepatic encephalopathy: Beyond psychometric testingMetabolic Brain Disease, 2022
- Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable AccessLiver Transplantation, 2021
- Predicting Overt Hepatic Encephalopathy for the Population With CirrhosisHepatology, 2019
- A risk score to predict the development of hepatic encephalopathy in a population‐based cohort of patients with cirrhosisHepatology, 2017
- Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute‐on‐chronic liver failure patientsLiver Transplantation, 2016
- The model for end-stage liver disease (MELD)Hepatology, 2007